GLAND PHARMA LTD.

NSE : GLANDBSE : 543245ISIN CODE : INE068V01023Industry : Pharmaceuticals & DrugsHouse : Private
BSE1779.352.2 (+0.12 %)
PREV CLOSE ( ) 1777.15
OPEN PRICE ( ) 1776.85
BID PRICE (QTY) 1779.50 (32)
OFFER PRICE (QTY) 1780.75 (18)
VOLUME 8194
TODAY'S LOW / HIGH ( )1761.55 1784.30
52 WK LOW / HIGH ( )861.5 2195.75
NSE1781.304.4 (+0.25 %)
PREV CLOSE( ) 1776.90
OPEN PRICE ( ) 1782.95
BID PRICE (QTY) 1781.05 (134)
OFFER PRICE (QTY) 1781.35 (17)
VOLUME 55664
TODAY'S LOW / HIGH( ) 1761.05 1784.70
52 WK LOW / HIGH ( )861 2194
Exchange
Period From    
Period To    
Exchange Deal Date Client Name Tran Qty (000's) Trade Price () Value (Rs.in Lakhs) Close Price ()

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.